Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
The October issue of ACP Hospitalist reports on innovations that hospitalists developed to respond to a variety of problems posed by the pandemic, care challenges before and after ICU stays, politics, parenting, and other topics.
Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
A study found that replacing 30-day readmission rates with a measure of excess days in acute care would change about a quarter of penalties for targeted conditions under the Hospital Readmissions Reduction Program.
Fewer than one-quarter of adults received medication for opioid use disorder (OUD) in the three months after discharge for injection drug use-associated endocarditis, and OUD treatment was associated with reduced mortality risk only in the month when patients were receiving it.